Symmetrel Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Combination Treatment With Cerebrolysin and Amantadine on Patients Who Stays in Prolonged Disorders of Consciousness Due to Severe Traumatic Brain Injury
Conditions:   Brain Injuries, Traumatic;   Disorder of Consciousness Interventions:   Drug: Amantadine Sulfate plus Cerebrolysin;   Drug: Amantadine Sulfate;   Drug: Cerebrolysin Sponsors:   Konkuk University Medical Center;   Ever Neuro Pharma GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2020 Category: Research Source Type: clinical trials